Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Is Lithium Americas Stock Still a Buy?
George Budwell
|
Sep 26, 2025
The U.S. government may take a 10% equity stake in this domestic lithium producer -- but dilution concerns clash with the de-risked path to 2028 production.
Why Lithium Americas Stock Almost Doubled Today
Rich Smith
|
Sep 24, 2025
President Trump keeps taking stakes in strategic industries.
Larimar Beats Q2 Loss Estimates
Motley Fool Markets Team
|
Aug 14, 2025
Why Shares of EnerSys and Ameresco Are Soaring This Week, but Lithium Americas Is Crashing
Scott Levine
|
May 24, 2024
While some green energy stocks are charging higher, one lithium stock is the subject of considerable skepticism.
3 Surprising Ways to Hedge Against Inflation
Adam Spatacco
|
Apr 30, 2024
While the stock market has demonstrated some resiliency in the face of lingering inflation, investors have other opportunities too.
Want to Invest Like a Billionaire? This ETF Lets You Buy SpaceX, OpenAI, Stripe, and Other Unicorns for Less Than $50.
Adam Spatacco
|
Apr 20, 2024
Investing in start-ups has wide appeal, and this fund allows you to mimic the moves of high-profile billionaires.
Why Akanda Stock Blasted Nearly 14% Higher Today
Eric Volkman
|
Mar 21, 2022
The company's top shareholder opens its first dispensary in Los Angeles.
Why RedHill Biopharma Blasted 12% Higher Today
Eric Volkman
|
Oct 4, 2021
The company's Opaganib might have a promising future, after all.
Why RedHill Biopharma Stock Is Getting Crushed Today
George Budwell
|
Sep 14, 2021
A clinical failure is sending shareholders to the exits this morning.
Why RedHill Biopharma Stock Jumped on Tuesday
Cory Renauer
|
Aug 31, 2021
An analyst on Wall Street thinks the company's commercial and development pipeline has been underestimated.
View More Articles